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HYPOTHESIS 
Patients following decompressive craniectomy for head injury with residual cognitive, 
behavioural, executive function or neurological deficits will show objective improvement in these 
parameters following cranioplasty. 
 
 
 
 
AIMS AND OBJECTIVES: 
The aims and objectives of this study are: 
• To assess cognitive, behaviour and executive status of patients before and after 
cranioplasty using appropriate psychometric tests 
• To assess motor power using MRC grading before and after cranioplasty 
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INTRODUCTION 
Decompressive craniectomy has been performed in patients with lesions causing 
raised ICP that can not be directly treated, such as malignant brain edema caused by 
infarction or trauma. The aim of the procedure is to decrease the mass effect, thereby 
preventing brain ischemia, herniation and death.  
Cranioplasty is a surgical procedure performed on patients where a portion of the 
skull removed during the decompressive surgery is replaced by autologus bone graft or 
artificial bone. The main objectives of cranioplasty are to restore the normal barriers 
protecting the intracranial structures, obtain a satisfactory cosmetic result and achieve a 
permanent or very durable reconstruction using biologically inert materials. However, there 
are many theories suggesting that cranioplasty may improve underlying physiological 
abnormalities caused by the lack of bone, and there are several reports of improvements in 
cognition and / or motor power following cranioplasty for large cranial defects.  There has to 
date been no prospective study documenting improvement in patients with craniectomy 
defects and stable neurological deficits.  Hence we undertook this prospective study to assess 
cognitive and neurological functions outcome of patients before and after cranioplasty using 
appropriate psychometric tests.                      
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REVIEW OF LITERATURE 
DECOMPRESSIVE CRANIECTOMY 
           
High intracranial pressure (ICP) is the most frequent cause of death and disability 
after a severe traumatic brain injury (TBI).  High ICP that is not caused by a surgically 
removable abnormality is usually treated in a graded manner by maintaining blood pressure 
and oxygenation, normothermia, sedation, CSF drainage, moderate hypocapnea, mannitol and 
other medical measures. When these fail to control high ICP, second-line therapies are 
initiated, which include barbiturate coma, hyperventilation and moderate hypothermia.  When 
medical measures fail to control ICP, removal of generous segments of bone as a 
decompressive craniectomy can be used (opening the box), allowing the brain space to 
expand and consequently reduce high ICP (4).  
The rationale for decompressive surgery is based on theMonro-Kellie law. According 
to this doctrine intracranial volume remains constant and volumetric compensations should 
be achieved by shifts in CSF, cerebral blood volume, or brain herniations. Removing a 
variable amount of bone, leaving the dura mater open or augmented by a duraplasty, is a fast 
and effective means of increasing intracranial volume, reducing elevated intracranial pressure 
and increasing the compliance of the intracranial space (5).  The mean ICP decreased from 24 
to 14.6 mm Hg after decompression, as reported by Aarabi et al (5). 
The calculations of Münch et al (6) and Alexander et al (7) indicate that, 
decompressive craniectomy is efficacious in adding to the available intracranial volume. It 
significantly reduces intractable intracranial hypertension and improves brain tissue 
oxygenation, brain compliance, cerebral blood flow, pressure reactivity, and cerebrovascular 
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resistance. Each of these factors contribute to decreasing the pathophysiological cascades, 
particularly those augmented by ischemia, that result in secondary brain injury. 
 
Types of surgical decompression 
Decompressive craniectomy can be performed in two completely different situations: 
• Prophylactic decompression or primary decompressive craniectomy is defined as any 
surgical decompression performed, with or without brain tissue removal, in patients 
undergoing surgery primarily for the evacuation of any type of intradural lesion. The 
aim of prophylactic craniectomy is not to control refractory ICP but to avoid expected 
postsurgical increases in ICP. (8). 
• Therapeutic decompression or secondary decompressive craniectomy (S-DC) is 
defined as the procedure performed in patients in whom continuous ICP monitoring is 
conducted and in whom high ICP is refractory to medical treatment. This therapeutic 
option is used in some centres after first or second line therapeutic measures have 
failed to control ICP. (9).  
 
Indications 
Decompressive craniectomy is most commonly performed for traumatic brain injury 
(TBI) and ischemic stroke. The generally accepted guidelines (10, 11) for decompressive 
craniectomy are: 
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• Age < 50 years 
• Brain swelling on CT scan, unilateral or bilateral with correlating clinical    
deterioration. 
• No fatal primary brain injury with irreversible brainstem signs or herniation 
with neurological pons signs  
• Refractory intracranial hypertension (> 30 mm Hg) 
• Intracranial hypertension with deterioration in clinical status (GCS score, 
mydriasis), or an increase in pulsatility index with decrease in diastolic flow 
on transcranial Doppler ultrasonography (TCD). 
Other reported entities that have been treated with DC include subarachnoid 
haemorrhage, venous thrombosis, toxoplasmosis, Reye’s syndrome and encephalitis.  
Leaving the bone flap off if the brain is swollen and tense after the evacuation of a mass 
lesion is also a widely accepted practice . (10, 11) 
 
Rationale of Decompressive Craniectomy in traumatic brain injury 
Decompressive craniectomy as an option for managing refractory intracranial 
hypertension remains controversial but is rapidly regaining popularity. Despite many small 
series and case reports indicating the beneficial effect of secondary decompressive 
craniectomy on the outcome for patients with severe TBI and increased refractory ICP, no 
controlled clinical trial has proved that this procedure is more effective in improving outcome 
than maximal medical therapy in an adult population. However, it would be acceptable to 
include this procedure as a rescue therapy in patients for whom maximal medical treatment 
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has failed to control ICP (4).  However, the only randomised controlled study was performed 
by Taylor et al in the paediatric age group (n = 27) and showed better outcomes both in terms 
of mortality and severe disability in the early decompressive craniectomy group (12). There 
are two ongoing randomized controlled trials of decompressive craniectomy (RescueICP and 
DECRA) that will allow further conclusions on the efficacy of this procedure in adults. 
  Experimental models in the late 1960s and early 1970s showed that decompressive 
surgery was highly effective in reducing mortality in unilateral brain swelling. However, 
Moody et al commented that although unilateral hemicraniectomy significantly improved 
mortality in dogs with unilateral brain swelling, “the quality of life among the survivors has 
not been good” (4). A Cochrane review (2006) recommended decompressive craniectomy 
may be justified in some children with medically intractable ICP after head injury but 
concluded there was no evidence to support its routine use in adults (4).  EBIC and NICE 
(UK) recommend decompressive craniectomy as an option for refractory intracranial 
hypertension in all ages.  The North American Brain Trauma foundation suggests 
decompressive craniectomy may be the procedure of choice in the appropriate clinical 
context and also considering the use of decompressive craniectomy in the first tier of TBI 
management (10, 11).  Therefore, it is obvious that level 1 evidence is required to clarify 
which subset of patients with severe TBI would benefit from decompressive craniectomy but 
it is increasingly clear that use of decompressive craniectomy combined with modern 
neurointensive care offers the potential to save life with acceptable functional outcome. In 
many parts of the developing world where ICU facilities are limited, decompressive 
craniectomy has proved a cost-effective therapy and hence has always remained popular. 
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Complications of decompressive craniectomy 
 Complications of any procedure have major ramifications on the risk-benefit balance 
in decision making during evaluation of potential surgical candidates.  An understanding of 
the pathophysiological events that accompany removal of a large piece of skull bone provides 
a foundation for understanding many of the complications associated with decompressive 
craniectomy. One of the reasons that decompressive craniectomy fell out of favour was 
intraoperative complications such as excessive blood loss, due to the fact that is was usually 
performed as an emergency by comparatively junior surgeons.  Expansion of contusions, new 
subdural and epidural hematomas contralateral to the decompressed hemisphere and external 
cerebral herniation are the early postoperative complications of decompressive craniectomy 
for TBI. Within the first week following decompression, CSF circulation derangements 
manifest commonly as subdural hygromas. Paradoxical herniation following lumbar puncture 
in the setting of a large skull defect is a rare, potentially fatal complication that can be 
prevented and treated if recognized early. During the later phases of recovery, patients may 
develop a new cognitive, neurological, or psychological deficit termed syndrome of the 
trephined (36, 74). 
 
SYNDROME OF THE TREPHINED (SINKING SKIN FLAP SYNDROME) 
“Syndrome of the trephined” is an unusual syndrome in which neurological 
deterioration occurs following removal of a large skull bone flap. This syndrome is 
experienced by an unknown proportion of patients following large craniectomy and manifests 
as a combination of clinical symptoms which may include postural headaches and dizziness, 
various degrees of focal neurological deficits as well as impaired memory, concentration and 
cognitive function as first described by Grant and Norcross in 1939 (13). In the majority of 
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patients the symptoms are mild or moderate, but in some patients they significantly affect 
outcome and rehabilitation. Fodstad et al  believed that only symptoms reduced or relieved by 
cranioplasty should be included in the definition of “syndrome of the trephined.”(16). 
In 1977 Yamura and Makino coined the term “syndrome of the sunken skin flap 
(SSFS)” as serious disabling neurological deficits and impairment of the general status with 
concave deformity and relaxation of the skin flap, which develop several weeks to months 
after large craniectomy. The neurological symptoms of SSFS they described included 
headache, vertigo, tinnitus, fatigue, loss of concentration, loss of memory, depression, 
dysphagia, apraxia, paresis of extremities, and convulsions. (14).  They stated that "the  
syndrome of the sinking skin flap,"  should  not be confused with the “syndrome of  the 
trephined” or  “the post-traumatic syndrome”,  which are mainly related to subjective 
complaints with significant psychic or  neurotic  components, excepting the presence of  
headache . The term “motor trephine syndrome” has been used to describe a delayed motor 
deficit occurring after decompressive hemicraniectomy, which reverses rapidly following 
cranioplasty (15).  
 
Pathophysiology of the Syndrome 
The first pathophysiological explanation for this syndrome was suggested by Gardner 
et al (27) in 1945, who felt that unlike the brain in the closed calvarium, in a trephined skull 
the brain pulsates with every alteration of arterial or venous pressure. According to this 
hypothesis, the in-and out pathologic movement of the brain is responsible for the symptoms, 
and therefore an immobilizing cranioplasty should relieve these symptoms. 
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Tsukasa et al proposed mechanism of SSFS was that a large cranial decompression is 
generally performed to reduce high intracranial pressure, and the cranial defect produced by 
craniotomy is directly affected by atmospheric pressure.  As cerebral swelling improves, the 
skin at the cranial defect gradually sinks due to atmospheric pressure to deform cerebral 
tissue, resulting in decreased cortical blood perfusion and cerebral dysfunction (19). 
There have been various other theories proposed for the occurrence of this interesting 
syndrome. A list of the theories that suggest reasons for neurological deficits after 
decompressive craniectomy are briefly summarized below:  
1. Compression of the Underlying Cortex by an Infolded Scalp:  The removal of a large 
bone segment will leave the cranium with a flaccid area of scalp, which as a result of 
the gradient between atmospheric pressure and ICP will displace inwardly and press 
on the cortex (14, 17). 
2. Changes in cerebral blood flow:  Radiological studies including xenon CT, perfusion 
CT, and dynamic CT imaging have shown improvement in CBF following 
cranioplasty at the site of the craniectomy, and at distant sites including the opposite 
hemisphere (14, 16, 18, 19). The reduction in CBF in the patient who undergoes a 
craniectomy can occur because of a deformity of intracranial structures, transmission 
of atmospheric pressure to the cerebral vasculature, and impairment of venous return 
as a result of local compression by the inwardly depressed scalp (14). 
3. Cerebrospinal Fluid Hydrodynamics: Fodstad et al observed changes in CSF 
hydrodynamic parameters that could be caused by the atmospheric pressure acting 
directly on the underlying cerebral tissue in the absence of a bone flap (16). In the 
upright position the ICP is normally negative in a closed skull. If there is a cranial 
defect present the ICP will tend to equalize with the atmospheric pressure, which in 
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turn will cause an increase in the ICP if the patient is in the sitting position. The 
removal of a large bone segment will leave the cranium with a more or less flaccid 
area that should contribute to changes in elastance and volume variables, and such 
changes were identified in their patients. Similar findings are noted in animal studies 
as well (18).  This has been demonstrated by the fact that the neurological status of 
the patient can occasionally be strongly related to posture. Kumar et al described the 
worsening of left hemiparesis in the sitting position and sunken skin flap in the right 
frontoparietal region which improved with cranioplasty. (20). Nakamura et al noted 
prompt reversal of speech worsening and right hemiparesis after moving the patient to 
a horizontal or Trendelenburg position, along with restoration of the curvature of the 
scalp flap (21) . Guido and Patterson described 2 patients with a combination of a 
skull defect and a lumbar CSF leak with a dramatic change in neurological status 
related to posture.  Both patients had blood injected into the epidural space of the 
lumbar theca, with excellent clinical recovery and a filling out of the sunken 
decompression site (21). Bijlenga et al found that, a patient with orthostatic sinking of 
the skin flap along with parkinsonian tremor, abducens nerve palsy, and mydriasis. 
All of these signs resolved soon after the patient lay down and after cranioplasty (23). 
Joseph et al reported a case of large craniectomy defect presented with low GCS with 
CT scan revealed worsening of the midline shift. There was reduction of midline shift 
and improvement in sensorium on lowering patient’s head below the horizontal by 
10° and patient made an excellent recovery with no evidence of neurological deficits 
after cranioplasty (24). 
The goal of treatment in patient with the syndrome of the sinking skin flap is 
restoration of the pressure differential between the intracranial compartment and the 
atmosphere, which should correct the imbalances described above.  In 1945 Gardner first 
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described clinical improvement after cranioplasty with tantalum mesh. Segal et al suggested 
that cranioplasty improves the neurological deficits by a decrease in local intracranial 
pressure, and correction of abnormal CSF dynamics (25).  Another report suggested that the 
cranioplasty may affect postural blood flow regulation, cerebrovascular reserve capacity and 
cerebral glucose metabolism (26). 
 
 
 
 
CRANIOPLASTY 
Cranioplasty is the surgical correction of skull defects to protect the brain, to 
normalize intracranial pressure relationships and possibly alleviate neurological deficits 
resulting from cranial bony defects, and to provide reasonable cosmetic result (13, 15, 16, 17, 
21, 24, 25, 27) 
 
History 
Cranioplasty, the repair of a skull vault defect by insertion of some object (bone or 
non-biological materials such as metal or plastic plates), is a well known procedure in 
modern neurosurgery(1), but repair of skull defects paralleled the practice of  trepanation 
among ancient cultures(2,3).    
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              Cranioplasty is among the oldest surgical procedures performed on the skull.  
Trauma, infections, tumors and compression caused by brain edema were some of the reasons 
for the removal of bone (3), and cranioplasty with varied materials was performed by many 
ancient civilizations dating back to 3000 BC, particularly the Inca period in Peru (28).   The 
first recorded description of a true cranioplasty was made by Fallopius (1523-1562) and 
Petronius in 1565, who stated that the cranial bone could be replaced with a gold plate (29).  
The first successful bone graft cranioplasty was reported in 1668 by Job Janszoon van  
Meekeren, who successfully repaired a cranial defect using a dog’s bone and definitely 
opened the way to the modern concept of cranioplasty(29). The number of cranioplasties 
increased during the 19th and 20th centuries when soldiers suffered cranial defects from war-
related injuries (29). 
 
Indications for cranioplasty 
Cranioplasty is not only useful for cerebral protection and improvement of 
appearance, but it is also useful for improving neurologic symptoms. Grand et al(13) have 
performed an extensive literature review in neurological improvement after cranioplasty and 
given the indications for cranioplasty. They are: 
• Severe headache and other symptoms of the syndrome of the trephined such as 
dizziness, undue fatigability, vague discomfort at the site of the defect, a feeling of 
apprehension and insecurity, mental depression and intolerance to vibration. 
• Epilepsy, when the attacks originated from the injury that caused the defect. 
• Those cases in which there is danger of trauma at the site of the defect. 
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• Cases that have an unsightly defect. 
• Defects that pulsate unduly or that are painful. 
 
Contraindications for cranioplasty 
The contraindications are: 
• The presence of any possible infection in either brain or bone. 
• Increased cerebrospinal fluid pressure that is not easily reducible by lumbar puncture. 
 
 
Timing of cranioplasty 
From a practical point of view, the timing of reconstructive surgery is important. 
Several large centres, especially in developed countries, repair the skull defect during the 
same admission, once the ICP has become normal.  Though Gardner stated that the syndrome 
of the trephined  would not occur  if  skull  defects  were  repaired  immediately (27), it is 
generally agreed that the interval between complex wounds and cranioplasty should be 
between 3 and 6 months and as long as a year when there is a wound infection to avoid the 
complication of osteomyelitis. However, Fosdstad observed that patients who benefited most 
from cranioplasty were those in whom there were large defects near the dural sinuses with a 
concave deformity of the skin flap that allowed transmission of the atmospheric pressure 
directly to the cerebral cortex. Such cranial defects should therefore be repaired as early as 
possible (8). 
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In this context, one should recall the experience, published in 1979, of Berkley and 
coworkers, who reviewed 491 cranioplasties and found that complications of original injury 
and debridement increase the morbidity rate of cranioplasty and concluded that it was 
necessary to wait at least a year after penetrating or complex head injuries to ensure a good 
outcome (30, 32). 
James et al advised not to attempt a primary repair after craniocerebral trauma, but to 
wait for at least two months if the wound heals by first intention. If there has been initial 
infection, plating should be deferred for at least six months, and longer in cases of infection 
with penicillin-resistant bacteria (42). 
 
 
Cranioplasty and outcome 
1. Cranioplasty and epilepsy:  Cranioplasty has been said to exert a beneficial effect on 
posttraumatic epilepsy. For  this  reason, many surgeons have  advocated  the  early  
repair  of  a  cranial defect  to  prevent  the  occurrence  of,  or  to reduce  the  
frequency  of  seizures  occurring after  a  head  injury. (13, 16)  On the other hand, 
some  authors  have  found  no  convincing  evidence  of such  a  beneficial  effect 
(30, 32, 38).  Gardner found  that,  an early  cranioplasty  would  prevent  epilepsy 
since the  "cranioplasty would eliminate progressive  atrophy  due  to  pulsations  of  
the mobilized brain", and he  reported  that  6  out of  10  patients  suffering from 
posttraumatic or postoperative epilepsy were relieved of seizures for 10-48  months 
and they found  that  electroencephalograms  after cranioplasty  were  improved  as 
compared to  preoperative  records (33).   
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2. Effect of cranioplasty on syndrome of trephined and motor deficits:  It has proposed 
that cranioplasty should be performed not only for cosmetic and protective reasons, 
but also for post-traumatic syndromes as well as motor deficits that could be due to a 
bone defect.  Yamaura et al  reported  that  neurological  deficits such as hemiparesis,  
sensory  disturbance,  aphasia  and sinking flap syndrome improved  dramatically  
after  cranioplasty (14). Grantham  and  Landis stated  that almost every partially 
aphasic patient became able to use  more  words  after  cranioplasty  and  one patient  
who  was  able  to  use  only  10  words before  cranioplasty became able to use 190 
words within a week  postoperatively (50).   
Liang W et al (35) reviewed 23 patients undergoing early cranioplasty (5-8 weeks 
after craniectomy) in the last 4 years with a detailed choice of patients, outcome of 
complications after head trauma and large craniectomy, as well as assessment of 
prognosis. The early outcome (1 month later) revealed most of the patients who had 
disturbances in conscioiusness before the cranioplasty recovered improved, with 
improvement in deficits as well. The longer term prognosis (18 months later) revealed 
that 17 patients made a good recovery (independent patients) in this series (74%), 
whereas four patients survived with a severe disability (17%) and two remained in a 
vegetative state (9%). 
Chang Hyun Oh (34) did a retrospective comparative study of outcomes between 
shunting after cranioplasty and cranioplasty after shunting in large concave flaccid 
cranial defect with hydrocephalus. The aim of this study was to evaluate the 
difference of outcomes between in the shunting after the cranioplasty (n=10, group 1) 
and the cranioplasty after the shunting (n=13, group 2) in a large flaccid cranial defect 
with posttraumatic hydrocephalus. The outcomes were compared in two groups 6 
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months later. Improvement of Glasgow outcome scale (GOS) was seen in 8 cases 
(80.0%) of total 10 cases in group 1, and 6 cases (46.2%) of 13 cases in group 2. 
Three (75.0%) of 4 cases with hemiparesis in group 1 and 3 of 6 cases (50.0%) in 
group 2 improved. All cases (2 cases) with decrease of visual acuity showed 
improvement in each group. Dysphasia improved in 3 of 5 cases (60%) in group 1 and 
4 of 6 cases (66.6%) in group 2. 
Stiver (36) evaluated patient demographics, injury characteristics, detailed motor 
examinations, and CT scans in 38 patients with long-term follow-up after 
decompressive hemicraniectomy for TBI.  Ten patients (26%) experienced delayed 
contralateral upper-extremity weakness, beginning 4.9 ± 0.4 months (mean ± standard 
deviation) after decompressive hemicraniectomy. Motor deficits improved markedly 
within 72 hours of cranioplasty repair, and all patients recovered full motor function. 
The CT perfusion scans, performed in 2 patients, demonstrated improvements in 
cerebral blood flow commensurate with resolution of cerebrospinal fluid flow 
disturbances on CT scanning and return of motor strength. Comparisons between 10 
patients with and 20 patients (53%) without delayed motor deficits identified 3 
factors—ipsilateral contusions, abnormal cerebrospinal fluid circulation, and longer 
intervals to cranioplasty repair—to be strongly associated with delayed, reversible 
monoparesis following decompressive hemicraniectomy. Delayed, reversible 
monoparesis, also called motor trephine syndrome, is common following 
decompressive hemicraniectomy for TBI. 
Erdogan et al (37) studied eighteen patients who underwent cranioplasty, and found 
that in fourteen patients with syndrome of trephined and five patients with 
hemiparesis had improvement after cranioplasty.  Primrose reviewed 42 cases, I9 of 
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whom were cured of their complaints, eight improved, five unchanged, and two made 
worse. Shuttleworth  reported seven cases, four of whom were relieved of their 
complaints and two improved, while one was the same as before operation(13). 
Termier was able to follow 63 cases that had been done over 25 years and he felt that 
only a few epileptics or psychotic patients had been improved, but that the majority of 
the trephine syndromes had been cured or greatly benefited(13).  
Boinet reviewed 41 cases of cranioplasty and 95 cases of cranial defect that had not 
been repaired and found that there were no significant differences between the 
symptomatology of the cases whose defect had been filled and those in whom it was 
still open (13).  Lockhart et al stated that precranioplasty headaches, visual 
disturbances, difficulty in speech, convulsions, weakness of extremities and mental 
impairment were not changed by the repair of the cranial defect. (30, 40) 
 
3. Effects of cranioplasty on cerebral hemodynamics:  Restoration of cerebral 
hemodynamics as an explanation for recovery after cranioplasty were proposed by 
some studies. Yoshida et al studied cerebral blood flow and metabolism in seven 
patients with stable 133Xe computed tomography and 31P MRS and demonstrated the 
increase of cerebral blood flow and improvement in neurological deficits after 
cranioplasty (38).  Winkler et al investigated cerebral blood flow reactivity with TCD 
and cerebral glucose metabolism with positron emission tomography in 12 patients 
and reported that cranioplasty has a role in improvement in cerebral blood flow as 
well as improvement of cerebral vascular reserve capacity (26). 
Thirteen patients were studied by Chung-Ching Chio to assess postoperative changes 
in neurological status and blood flow velocity using TCD. The results showed 
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significant improvements after cranioplasty in GCS, arm muscle power, and Barthel 
Index. While the CBF velocities tended to increase after cranioplasty, only the 
increase in the non-lesion side middle cerebral artery (MCA) was statistically 
significant. The interval from decompressive craniectomy to cranioplasty and 
neurological status change before and after cranioplasty was significantly negatively 
correlated so that they conclude that cranioplasty can improve neurological status, and 
it should be performed as earlier as edema has resolved (40). 
 
Complications of cranioplasty 
Complications are relatively common after cranioplasty, being reported up to 23.6% 
of cases (44). Postoperative infection, osteomyelitic bone flap and necrosis of the flap are the 
commonest (14, 43, 44, 45).  However there are some report of cerebrospinal  fluid  fistula  
from fractured  acrylic cranioplasty plate (41),  fracture  of  the  resin  plate(14),  resorption  
of  preserved  autografts  and calvarial hemangioma at site of cranioplasty (42).  
The majority of complications due to latent foci of infection that have made 
themselves manifest after cranioplasty in view of presence of foreign body. Currently, an 
incidence of infectious complications less than 5% is considered acceptable (27).   The 
incidence of infection has been reported as 3.3% (14), and 3.7% (30). The infection rate of 
cranioplasty depends on several factors: material used, site and size of the defect, previous 
wound infection and others (44). 
The incidence of late complications in a pediatric population was reported as high as 
23%. It was related to the thinner scalp, continued skull growth and greater activity level of 
the child (45).  However age was not a significant risk factor in the adult population (46). 
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Although the autogenous bone remains the preferred option, infection and graft 
absorption are common complications of the cranioplasty using frozen autogenous bone graft 
(46, 47). The infection rate of the autogenous bone was reported as 0-33% (44, 47). PMMA is 
the most frequently used alloplastic material. The infection rate is rather lower than the 
autogenous bone graft, being reported as 1-16% (44, 48). 
The size of the defect may influence on the infection rate (45).  Park et al defined a 
small defect as a size of less than 75 cm2 and a large defect as more than 125 cm2. The 
infection rate was 6.9% in small defects, 11.1% in middle sized defects, and 37.5% in large 
defects. The size was the only difference that reached statistical significance in his study (44). 
Berkley and colleagues in 1979 found that cranioplasties taking place 1–6 months 
after craniectomy had the highest complication rate (7.9%) and those performed 12–18 
months after craniectomy had the lowest complication rate (4.5%) (30).  
Reid Gooch has done analysis of 62 cases after cranioplasty and stated that patients 
undergoing a bifrontal craniectomy are at significantly increased risk for postcranioplasty 
complications, including the need for reoperation as compared to unilateral 
frontotemporoparietal (FTP) cranioplasty (49).  This is probably due to the proximity of the 
skull defect to the paranasal sinuses (44, 45, 47, 49). 
 
Materials used for cranioplasty 
The development of ideal cranioplasty materials has been a continuing medical and 
bioengineering challenge. To be suitable  for  cranioplasty,  it must meet  several  criteria.  
The material should be (51): 
• Malleable, to achieve a good cosmetic result 
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• As strong as bone, to secure adequate protection 
• Lightweight, to avoid patient discomfort 
• Chemically inert and noncarcinogenic 
• Nonferromagnetic, to allow CT scanning and magnetic resonance imaging to be 
performed 
• As inexpensive as possible  
• In  children,  the material  should  be  able  to  allow  the  skull  to grow .  
Certain factors determine whether autologous bone grafts and / or biomaterials should 
be used in a particular case. Bone grafts appear to have a low infection rate in most studies 
reviewed, and the stimulatory effect of autologous bone transplants on local bone 
regeneration is also important (51, 52, 53, 54). The disadvantages include enhanced 
morbidity and risk for complications from donor site when harvesting the graft (55, 56), 
resorption of transplanted bone (57, 58) and availability of limited amount of donor bone for 
the reconstruction of large defects. On the other hand, the general advantages of using 
biomaterials include no donor-site morbidity, shortening of operating time and hospital stay 
(56). The disadvantages are higher infection rates in some studies and costs (44, 56 , 59, 60). 
However, the eventually decreased morbidity and shortening of hospital stay may tilt the 
balance towards the use of biomaterial. 
Materials used for cranioplasty include: 
• Bone grafts 
o Autografts  
o Allografts. 
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• Biomaterials 
o Methyl methacrylate (PMMA) 
o Hydroxyapatite   
o Calcium phosphate 
o Porous polyethylene 
o Titanium  
o Combined biomaterials.  
Sanan and Haines (62) published an excellent historical review of cranioplasty and  
listed the materials and techniques that have been used from ancient times to the present. 
They conclude that allografts, which have been used for centuries, carry resorption and 
infection rates that are too high. Use of metallic and nonmetallic substitutes may also lead to 
several problems. But still PMMA is the most frequently used alloplastic material (44, 51, 63, 
64) and has long been used at our institution. Its advantage are ease of use, malleability and 
low cost, but being a foreign material may cause significant inflammation, producing a 
membrane at the interface between the host bone and the cranioplasty device (51). 
In recent years attempting to stimulate new bone formation by osteoinduction using 
growth factors has been tried. The use of porous ceramics may be ideal because they can 
provide osteoconduction in addition to the inductive effects provided from impregnated 
cytokines. Bone morphogenetic proteins (BMPs) have been used in a few human studies with 
promising results (61). However the introduction of biomaterials, including compounds with 
osteoinductive growth factors, for cranial bone repair needs to be accompanied with good 
prospective comparative studies to obtain conclusive results and create guidelines (61). 
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MATERIALS AND METHODS 
   
STUDY DESIGN 
 A prospective cohort interventional study design was employed to evaluate the post 
cranioplasty changes in cognition, executive functioning, behaviour, and motor power of 
selected traumatic brain injury patients with  large frontotemporoparietal or bifrontal 
craniectomy defects following cranioplasty. The assessments were done during the pre-
surgical period evaluation and every month during the follow up of three months. 
 
SAMPLING TECHNIQUE 
 In this study purposive sampling technique was used to select the sample. This 
method allows selecting individuals units by purposive method.  
 
SAMPLE SIZE CALCULATION 
 The sample size for the study was determined to be 20 traumatic brain injured 
patients with decompressive craniectomy defect. The sample size calculation was done by 
using the below formula. 
  n=4pq/d2     
 Using p= 27.7 from a previous study where ‘p’ was the proportion of patients who 
improved after cranioplasty; q= 72.3 from a previous study where ‘q’ was the proportion of 
the patients who did not improve after cranioplasty, where d = 19, then n = 21.  
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STUDY SITE AND PARTICIPANTS 
 The study was conducted in the Department of Neurological Sciences, Brain Injury 
Clinic (BIC) and the Department of Physical Medicine and Rehabilitation, Christian Medical 
College, Vellore.  Head injured patients with decompressive craniectomy defects who were 
being followed up in the BIC for were selected for the study using the following criteria.  
  
INCLUSION CRITERIA 
1. Traumatic brain injury patients with frontotemporoparietal or bifrontal 
craniectomy defect.   
2. Stable Addenbrook’s Cognitive Evaluation Scale-Revised (ACE-R) score and 
neurological deficits. 
3. Age between 15 to 60 
4. Patients (or caregivers when necessary) who were willing to participate 
 
EXCLUSION CRITERIA 
1. Patients in whom the Addenbrook’s Cognitive Evaluation Scale-
Revised (ACE-R) could not be administered.  
2. Patients with a pre-morbid history of psychiatric illness or dementia. 
3. Patients with contraindications for cranioplasty. 
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OUTCOME MEASURES 
Quantitative measures 
1. Addenbrook’s Cognitive Evaluation Scale – Revised: (see appendix)It is a 
brief neuropsychological test used for assessing cognition. It is reliable and 
sensitive in the early stages of dementia, and capable of differentiating 
subtypes of dementia including Alzheimer’s disease, frontotemporal 
dementia, progressive supranuclear palsy and other parkinsonian syndromes. 
The test was originally developed in the year 2000 (65) and revised in 2006 
(66), and has been adapted and validated in many languages including the 
South Indian language of Malayalam, (67) and the cut-off scores have been 
found useful across India. It has 5 subtests  
• Attention & orientation   
• Memory 
• Fluency of speech 
• Language 
• Visuospatial ability 
The alpha coefficient of the ACE-R is found to be 0.80 and its concurrent and 
convergent validity has been established (66). 
2. Mayo-Portland Adaptability Inventory-4: (see appendix)It was designed to assist 
in the clinical evaluation of people during the post acute period following acquired 
brain injury. MPAI-4 items represent the range of physical, cognitive, emotional, 
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behavioral, and social problems that a patient might develop after brain injury. 
The MPAI-4 consists of three subscales: 
• Ability (sensory, motor, and cognitive abilities) 
• Adjustment (mood, interpersonal interactions) 
• Participation (social contacts, initiation, money management).   
The test assesses highly developed and well-documented psychometric properties. 
A satisfactory overall person and item reliability has been found. Concurrent (68) 
and predictive validity (69) of the MPAI has been demonstrated in a number of 
studies.  
3. Key Behaviour Change Inventory (KBCI): (see appendix) (70)it is a 64-
item test that was developed to assess executive, interpersonal, and 
emotional functioning behaviors following TBI. The eight subscales of the 
test are to test for: 
• Unawareness 
• Inattention 
• Impulsivity 
• Apathy 
• Interpersonal difficulties 
• Communication problems 
• Emotional adjustment  
• Somatic difficulties.  
It has four questionnaires (pre and post intervention version for patients, 
and the same for the patient’s caregiver).  The psychometric properties of 
the test found adequate reliability (internal consistency coefficients range 
from .82 to .91), and it also has good content and construct validity (70). 
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4. Multiple Errands Test (MET):  This is a test to assess the executive 
functioning of a person by asking the subject to carry out activities in real life 
situations. It assesses  
• Planning 
• Prospective memory  
• Multi tasking.  
It is a 6 element test in which the subject has to organize their activities in order 
to carry out six tasks in a limited time period and without breaking certain rules. 
The task includes shopping, finding out certain information, and being in a 
particular place at a particular time. The modified version of MET has been used 
for the current study (see appendix) (71).  The inter-rater reliability of the test 
ranges from .81 to 1.00 (72).  Discriminant validity was satisfactorynfor the test 
(71). The errors were categorised using the definitions offered by Shallice and 
Burgess (see appendix) (73), namely:  
• Inefficiencies  
• Rule breaks  
• Interpretation failure  
• Task failure 
This task was performed with the help of a psychologist. 
5.  Medical Research Council (MRC) grading:  This is a reliable and validated 
scale for assessing muscle weakness. Each muscle group is graded as follows: 
• 0 - no movement  
• 1 - flicker of movement perceptible in the muscle  
• 2 – full range of movement with gravity eliminated  
• 3 – full range of movement against gravity  
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• 4 - can move against gravity & some resistance exerted by examiner  
• 5 - normal power 
 
Qualitative Measure 
Both the patient and caregiver were asked to fill a three point scale question (see 
appendix) to assess their subjective opinion about the improvement after cranioplasty. 
 
SELECTION OF PATIENTS AND ASSESSMENT PROCEDURE 
Head injured patients after decompressive craniectomy are regularly followed up in 
the Brain Injury Clinic (BIC) by a multidisciplinary team.  They were consecutively 
selected and assessed by clinical interview and recruited for the study by using inclusion 
and exclusion criteria.  The assessment began with administration of the ACE-R test, 
primarily for assessment of cognition.  If the cognitive scores were within normal limits 
(above 82) the patient was administered the Key Behavioural Change Index (KBCI) test for 
behavioural assessment.  If the KBCI results were within normal limits the patient was 
administered the Multiple Errands Test (MET) to test executive functions.  All patients were 
assessed using the MPAI-4 questionnaire (except the initial 4 recruited) and motor power 
using MRC grading.  
There was no definite protocol on how long after the decompressive craniectomy the 
cranioplasty was carried out. The difficulty we faced in trying to demonstrate the benefits of 
cranioplasty were to separate the effects of the procedure from the natural history of 
improvement.  We attempted to do so by performing the cranioplasty after a minimum 
period of six months after the initial surgery, and operating on patients only when their 
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neuropsychological scores and motor power had remained unchanged for 2 consecutive 
assessments at least one month apart.   
  
ETHICAL ISSUES  
The ethical concerns of this study were addressed using the following measures: 
1. Written informed consent from the patient or primary caregiver (appendix A) 
for participating in the study was obtained ensured voluntary participation. 
2. Reversible anonymisation as well as restricted access and disclosure of the 
data ensured the privacy of patients. 
3. The Institutional Review Board and Ethics Committee of Christian Medical 
College had reviewed and approved for the study. 
 
STATISTICAL PARAMETERS  
The data collected for study was coded and verified thoroughly. Subsequently, using 
SPSS-16 (Statistical Package for Social Science) all the data was analyzed in three steps. In 
the first step, the basic characteristics of study population were outlined using descriptive 
statistical parameters. In the second stage, for the main analysis of the study ( pre and post 
cranioplasty) Wilcoxon signed rank correlation was employed to assess significance.  In the 
third stage a subanalysis using Kruskal Wallis and Mann Whitney U test was employed to 
find out the improvement based on the original admission GCS, interval between 
decompression and cranioplasty and location of craniectomy defect.  The level of 
significance considered for all statistical parameters for the present study was .05. 
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RESULTS 
 
 The study results are presented in tabular form below, and each table described in the 
accompanying text. Table 1 shows the basic characteristics of the study population.  Though 
the sample size required was 20, and 20 patients were recruited, complete follow up 
assessment could only be completed for 15.  Nine (60.0%) patients were males and 6 (40%) 
were females. The age of the patients was categorized into three groups: 6 patients were 15-
30 years (40.0%), 8 patients (53.3%) were 31-50 years and one patient (6.7%) was above 51 
years.  The patients who participated in the study had their injury between 7 months to 24 
months before the date of cranioplasty. This interval was again categorised into three groups: 
7- 12 months (6 patients, 40.0%), 13 – 18 months (5 patients, 33.3%) and 19-24 months (4 
patients, 26.7%). The patients were also divided based on the GCS score at the original 
admission into mild head injury (3 patients, 20.0%), moderate head injury (10 patients, 
66.7%) and severe head injury (2 patients, 13.3%).   On the basis of type of decompressive 
craniectomy  patients had one of bifrontal (4 patients, 26.7%), right (6 patients, 40%) or left 
(5 patients, 33,3%) frontotemporoparietal decompressive craniectomy. 
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Table 1: Basic Characteristics of Study Population 
Variables Category Frequency 
(N=15) 
Percentage 
Male 9 60.0 Sex 
Female 6 40.0 
15-30 6 40.0 
31-50 8 53.3 
Age 
51 & above 1 6.7 
7-12 months 6 40.0 
13-18 months 5 33.3 
Duration between 
decompressive 
surgery and 
cranioplasty 19-24 months 4 26.7 
Mild 3 20.0 
Moderate 10 66.7 
GCS at original 
admission 
Severe 2 13.3 
Bifrontal 4 26.7 
Right FTP 6 40.0 
 Type of 
decompressive 
craniectomy 
Left FTP 5 33.3 
 
 
 Table 2 shows the Median, Interquartile range, z value, and P-Values of ACE-R. The 
number of  patients who were administered ACE-R is 15.  None of the subscales of the test 
demonstrated a significant difference after surgery.  The P-Value of tests of attention & 
concentration was .58 (pre op median: 18.00; post op median: 18.00). The P-Value of 
memory was .13, which suggests no significant difference between pre and post surgery (pre 
op median: 25.00; post op median: 26.00). The result of the subscales for fluency (pre op 
median: 7.00; post op median: 8.00; and P-Value .08), language (pre op median: 25.00; post 
op median: 25.00; and P-Value .35) and visuospatial functions (pre op median: 16.00; post op 
median: 16.00; and P-Value .49) also showed no significant improvement.  By contrast, there 
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was a significant improvement in the total ACE-R score after cranioplasty (pre op median: 
90.00; post op median: 92.00; and P-Value .02). 
 
Table 2: Median, Interquartile range, Z value and P-Values of ACE-R 
 
Median 
(N=15) 
Interquartile Range Variables 
Pre Op Post Op Pre Op Post op 
Z-
Value 
P-Value 
Attention & 
Orientation 
18.00 18.00 18.00-18.00 18.00-18.00 -5.57 .58 
Memory 25.00 26.00 22.00-26.00 24.00-26.00 -1.52 .13 
Fluency 7.00 8.00 4.00-8.00 6.00-9.00 -1.74 .08 
Language 25.00 25.00 24.00-26.00 25.00-26.00 -.94 .35 
Visuospatial 16.00 16.00 15.00-16.00 15.00-16.00 -.69 .49 
Total Score 90.00 92.00 82.00-92.00 87.00-94.00 -2.25 *.02 
*P-Value significant at .05 level 
 
 
 
Graph 1: Pre and Post op changes of ACE-R Total Score(Mean value) 
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 Table 3 below shows the results of sub scales and total score of MPAI-4. The total 
number of patients for whom MPAI administered was 11. This test was introduced into the 
Brain Injury Clinic protocol only after the first 4 patients in this study had already undergone 
surgery.  All subscales and the total score showed improvement after surgery.  The ability 
subscale (pre op median: 1.00; post op median: .00; pre op interquartile range: 00-4.00; post 
op interquartile range: 00-1.00; Z-Value -2.02; and P-Value .04), adjustment (pre op median: 
5.00; post op median: .00; pre op interquartile range: 1.00-10.00; post op interquartile range: 
.00-4.00; Z-Value -2.69; and P-Value .01), and participation (pre op median: 4.00; post op 
median: .00; pre op interquartile range: 2.00-7.00; post op interquartile range:  .00-4.00; Z-
Value -2.37; and P-Value .02) all showed significant changes, as did the total score (pre op 
median: 9.00; post op median: 3.00; pre op interquartile range: 5.00-18.00; post op 
interquartile range:  1.00-4.00; Z-Value -2.93; and P-Value .00). 
 
 
 
Table 3: Median, Interquartile range, Z value and P-Values of MPAI-4  
Median 
N=11 
Interquartile Range Variables 
Pre Op Post Op Pre Op Post op 
Z-Value P-Value 
Ability  1.00  .00 .00-4.00 .00-1.00 -2.02 *.04 
Adjustment 5.00 .00 1.00-10.00 .00-4.00 -2.69 *.01 
Participation  4.00 .00 2.00-7.00 .00-4.00 -2.37 *.02 
Total MPAI  
Score 
9.00 3.00 5.00-18.00 1.00-4.00 -2.93 **.00 
*P-Value significant at .05 level 
 **P-Value significant at .01 level 



 
Graph 2:Pre and Post in MPAI-4 Total(Mean value). 
 
 
 
Table 4 presents the median, interquartile range, Z value and P-values of KBCI of the 
patients. The value of the inattention subscale suggests no significant improvement after 
cranioplasty (pre op median: 14.00; post op median: 10.00; and P-Value .78). Impulsivity 
(pre op median: 14.00; post op median: 12.00; and P-Value .07), unawareness (pre op 
median: 16.00; post op median: 13.00; and P-Value .12), interpersonal problems (pre op 
median: 14.00; post op median: 13.00 and P-Value .62) and communication (pre op median: 
15.00; post op median: 12.00; and P-Value .10) scales also showed no statistically significant 
change after surgery.  However the apathy (pre op median: 15.00; post op median: 12.00; and 
P-Value .01), somatic (pre op median: 14.00; post op median: 12.00; and P-Value .03) and 
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emotional (pre op median: 15.00; post op median: 10.00; and P-Value .05) subscales showed 
significant improvement after cranioplasty.  The total score of KBCI also reveals no 
significant change after surgery (pre op median: 105.00; post op median: 95.00; and P-Value 
.06). 
 
Table.4: Median, Interquartile range, Z value and P-Values of KBCI of Patients 
 
Median 
(N=13) 
Interquartile Range Variable 
Pre Op Post Op Pre Op Post op 
Z-
Value 
P-
Value 
Inattention 
Problems 
11.00 10.00 9.00-13.50 8.50-13.50 -.28 .78 
Impulsivity 14.00 12.00 10.00-18.00 10.00-15.00 -1.79 .07 
Apathy 15.00 12.00 12.50-17.50 10.00-14.50 -2.81 *.01 
Unawareness 
problems 
16.00 13.00 11.50-20.00 11.00-17.00 -1.54 .12 
Interpersonal 
Problems 
14.00 13.00 11.00-18.00 11.50-17.00 -.49 .62 
Communication 
problems 
15.00 12.00 11.00-18.00 10.00-16.50 -1.65 .10 
Somatic 
problems 
14.00 12.00 12.00-20.50 10.00-15.50 -2.21 *.03 
Emotional 
problems 
15.00 10.00 13.00-18.00 9.00-17.00 -2.01 *.05 
Total score 105.00 95.00 94.00-138.50 85.00-122.50 -1.89 .06 
*P-Value significant at .05 level 
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Graph 3: Pre and Post operative KBCI Patient’s Total score(Mean value). 
 
 
 
 
 The fifth table shows the median, interquartile range, Z value and P-values of KBCI 
of the caregivers. Most of the subscales of the KBCI, namely inattention, impulsivity, apathy, 
unawareness, interpersonal problems and emotional problems  showed no significant 
improvement after cranioplasty (inattention: pre op median: 11.00; post op median: 10.00; 
and P-Value .37, impulsivity: pre op median: 13.00; post op median: 11.00; and P-Value .31, 
apathy: pre op median: 13.00; post op median: 10.00; and P-Value .08, unawareness: pre op 
median: 14.00; post op median: 11.00; and P-Value .10, interpersonal problems: pre op 
median: 13.00; post op median: 11.00; and P-Value .24, and emotional problems: pre op 
median: 14.00; post op median: 12.00; and P-Value: .22). On the other hand, the subscales for 
communication (pre op median: 13.00; post op median: 10.00; and P-Value .05) and somatic 
problems (pre op median: 19.00; post op median: 12.00; and P-Value .02) showed a 
statistically significant difference after surgery, as did the total score (pre op median: 104.00; 
post op median: 88.00; and P-Value .03).   
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Table.5: Median, Interquartile range, Z value and P-Values of KBCI of Relative 
 
Median 
(N=13) 
Interquartile Range Variable 
Pre Op Post Op Pre Op Post op 
Z-
Value 
P-
Value 
Inattention 
Problems 
11.00 10.00 9.00-13.50 9.00-14.50 -.89 .37 
Impulsivity 13.00 11.00 10.00-18.00 8.50-16.00 -1.02 .31 
Apathy 13.00 10.00 12.50-17.50 8.00-15.50 -1.73 .08 
Unawareness 
problems 
14.00 11.00 11.50-20.00 9.00-14.00 -1.64 .10 
Interpersonal 
problems 
13.00 11.00 11.00-18.00 11.00-14.00 -1.17 .24 
Communication 
problems 
13.00 10.00 11.00-18.00 8.00-12.50 -1.94 *.05 
Somatic 
problems 
19.00 12.00 12.00-20.50 11.00-17.50 -2.28 *.02 
Emotional 
problems 
14.00 12.00 13.00-18.00 12.00-14.00 -1.23 .22 
Total score 101.00 88.00 94.00-138.50 78.00-112.00 -2.12 *.03 
*P-Value significant at .05 level 
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Graph 4: Pre and Post operative changes of KBCI Total Score for Caregivers(Mean 
value). 
 
 
 
 
 
 The results of MET, median, interquartile range, Z value and P-values are given 
below in Table 6. The P-values of some subscales of MET, namely inefficiency, task failures 
and interpretation failure showed no statistically significant change after cranioplasty 
(inefficiency: pre op median: 1.00; post op median: 1.00; and P-Value .12, task failures: pre 
op median: 5.00; post op median: .4; and P-Value .53, interpretation failure: pre op median: 
1.00; post op median: 2.00; and P-Value .48). But the P-Values and median of rule breaks 
and the total error of MET shows significant improvement after surgery (rule breaks: pre op 
median: 3.00; post op median: .00; and P-Value .05, total score: pre op median: 10.00; post 
op median: 6.00; and P-Value .04).  
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Table.6: Median, Interquartile range, Z value and P-Values of MET 
 
Variable Median 
(N=15) 
Interquartile Range Z-
Value 
P-Value 
 Pre Op Post Op Pre Op Post op   
Ineffiency 1.00 1.00 .00-3.00 .00-1.00 -1.55 .12 
Rule Breaks 3.00 .00 .50-5.00 .00-1.00 -1.96 *.05 
Task Failures 5.00 4.00 3.00-7.00 2.50-6.50 -.06 .53 
 Interpretation 
Failures 
1.00 2.00 1.00-3.00 1.00-2.50 -.70 .48 
Total 10.00 6.00 7.50-17.00 5.00-12.50 -2.10 *.04 
*P-Value significant at .05 level 
 
 
 
Graph 5:  Pre and Post operative changes in MET Total Errors(Mean value). 
 


 As part of qualitative assessment, a self evaluation of improvement after cranioplasty 
was recorded after 3 months and results, frequency and percentages provided in table 7. In 
patient’s group 13 (86.7%) reported improvement, 1 patient (6.7%) reported worsening after 
surgery and 1 patient (6.7%) reported no change.  The same questions were administered to 
the caregivers, and 11 (73.3%) reported improvement while 4 (26.7%) there was no change.  
None of the caregivers reported any worsening.  
 
Table.7 Results of Qualitative assessment of Both Patient and their Relatives  
 
Qualitative Assessment Frequency 
(N=15) 
Percentage 
Improved 13 86.7 
Worsened 1 6.7 
Patient’s  
Same as before 1 6.7 
Improved 11 73.3 
Worsened None None 
Relative’s  
Same as before 4 26.7 
 
 
 
Graph 6: Patients’ Qualitative Assessment of Improvement 
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Graph 7:  Caregivers’ Qualitative Assessment of Improvement 
 
 
 
 
 5 out of the 15 patient had motor deficits preoperatively.  Three of them (60.0%) 
improved following surgery (one dramatically) while 2 (40.0%) were unchanged. 
 
Table 8: Improvement in Motor Power 
 
Motor Power Frequency 
(N=5) 
Percentage 
Improved 3 60.0 
Same as before 2 40.0 
Worsened None None 
 
 
Sub Analysis 
 As part of sub analysis Kruskal Wallis analysis and the Mann Whitney test were 
applied as appropriate to assess whether the other variables recorded – GCS at admission, 
interval between first admission and cranioplasty and the location of the craniectomy defect 
had any influence on the outcome.  The results are documented in tables 9 – 12.  The GCS at 
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admission affected only a few of the variables significantly (caregivers’ KBCI, especially 
between the mild and moderate injuries).  The interval between the first admission and 
cranioplasty and the location of the craniectomy deficit did not have a significant effect on 
the outcome. 
 
 
 
Table 9: Kruskal Wallis analysis of Original Admission GCS  
 
Scale GCS 
Category 
Median IQ X2 P-Value 
Mild 2.50 1.00-4.00 
Moderate 1.00 .00-9.00 
MPAI-4 
Severe 3.50 3.00-4.00 
.24 .89 
Mild 96.00 91.00-98.00 
Moderate 92.50 85.00-94.00 
ACE-R 
Severe 89.00 87.00-91.00 
3.36 .19 
Mild 85.00 76.00-113.00 
Moderate 94.00 87.75-112.50 
KBCI-Patient 
Severe 115.00 100.00-130.00 
1.28 .53 
Mild 76.00 76.00-77.00 
Moderate 96.00 82.00-149.25 
KBCI-Relative 
Severe 100.50 85.00-116.00 
6.45 *.04 
Mild 6.00 4.00-6.00 
Moderate 7.50 5.00-17.00 
MET 
Severe   
2.13 1.45 
 
 
 
Table 10: Mann-Whitney test of Admission GCS and KBCI Relatives Total Score 
 
GCS Category 
 
Median U-Value P-Value 
76.00 (N=3) Mild  Vs.  
Moderate  96.00 (N=8) 
.00 *.01 
76.00 (N=3) Mild Vs. 
 Severe 100.50 (N=2) 
.00 .08 
96.00 (N=3) Moderate Vs.  
Severe 100.50 (N=2) 
8.0 1.00 
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Table 11: Kruskal Wallis analysis of Interval between Decompression and Cranioplasty 
 
 
Scale Duration 
Category(months) 
Median IQ X2 P-Value 
7-12 1.00 01.00-04.00 
13-18 3.00 00.00-04.00 
MPAI-4 
19-24 9.00 00.00-11.00 
.91 .63 
7-12 94.50 91.00-96.50 
13-18 91.00 86.50-94.00 
ACE-R 
19-24 85.50 80.50-92.75 
5.52 .06 
7-12 90.50 82.75-104.50 
13-18 92.50 82.00-122.50 
KBCI-Patients 
19-24 115.00 105.00-144.00 
3.45 .18 
7-12 78.50 76.00-95.25 
13-18 86.50 80.50-109.00 
KBCI-Relatives 
19-24 163.00 101.00-175.00 
5.59 .06 
7-12 6.00 04.00-10.25 
13-18 12.00 07.00-17.00 
MET 
19-24 6.00 06.00-06.00 
1.85 .40 
 
 
 
 
 
Table 12:  Mann-Whitney test of Interval and KBCI Relatives Apathy 
 
Group Duration 
Category 
 
Median U-Value P-Value 
8.0 (N=5) I 
 
7-12months VS. 
13-18 months 10.00 (N=3) 
10.00 .66 
8.00 (N=5) II 7-12 months Vs. 
19-24 months 22.00 (N=3) 
.00 *.02 
10.00 (N=3) III 13-18 months 
Vs. 
19-24 months 
22.00 (N=3) 
1.00 .07 
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Table 13:  Kruskal Wallis analysis of Location of Defect and Outcome 
 
Scale Duration 
Category 
Median IQ X2 P-Value 
Bifrontal 4.00 1.75-9.25 
Right 2.00 .25-7.50 
MPAI-4 
Left 1.00 .00-4.00 
1.95 .38 
Bifrontal 91.00 84.25-94.00 
Right 91.50 85.25-96.50 
ACE-R 
Left 94.00 88.50-94.00 
.16 .92 
Bifrontal 105.00 89.75-128.50 
Right 105.00 80.50-137.00 
KBCI-Patient 
Left 89.00 82.00-98.25 
1.87 .39 
Bifrontal 85.50 77.00-154.00 
Right 101.00 76.50-139.50 
KBCI-Relative 
Left 86.50 80.50-103.00 
.05 .98 
Bifrontal 8.00 6.00-17.00 
Right 6.00 4.00-6.00 
MET 
Left 7.00 4.00-17.00 
2.40 .30 
 


 
DISCUSSION 
Introduction 
This study was designed to objectively assess the effect of cranioplasty on cognition, 
behaviour, executive and neurological functions in patients who initially underwent 
decompressive craniectomy after TBI.  The hypothesis was that there would be a significant 
improvement following the closure of the defect in the skull.  The change in function in these 
domains and the influence of other factors recorded are discussed below. 
 
The effect of cranioplasty in improving cognition 
The improvement in cognition after cranioplasty was assessed using ACE-R which 
gives better and rapid assessment of cognition when compared to other neuropsychological 
tests such as the MMSE.  Our results showed a statistically significant improvement in total 
score, though significant improvement could not be demonstrated in any of the subscales 
(attention and orientation, memory, fluency, language, visuospatial abilities).  A detailed 
review of literature shows there is very limited information available on the effect of 
cranioplasty on cognitive outcome. A study done by Anger et al showed significant 
improvement in major cognitive functions after cranioplasty assessed by Cognistat 
neuropsychological battery and EXIT interview.  Another study by Grantham and Landis 
stated  that almost every partially aphasic patient showed improvement in fluency after  
cranioplasty  and  one patient  who  was  able  to  use  only  10  words before  cranioplasty 
became able to use 190 words within a week (50).  
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For this study one of the exclusion criteria was inability to administer the ACE-R.  
The ability to cooperate for this test in itself implies a fairly good level of cognition, and it is 
possible that by excluding patients with poorer levels of function we have eliminated those 
who might have shown dramatic improvement.  This decision was deliberate, as assessment 
scales such as the Disability Rating Scale and Rancho Los Amigos score are comparatively 
crude measures and are used more for categorizing patients rather than serial assessment of 
neurological functions. This might be a reason for no statistical improvement in the 
subscales. 
 
Cranioplasty and behavioral disturbances 
Behavioral changes before and after cranioplasty was assessed using the behavioral 
change index (KBCI), which is completed by both the patient and caregiver.  This tool has 
eight subcales of behavior: inattention, impulsivity, apathy, unawareness of problems, 
communication, executive, behavioral, and emotional problems.  The caregiver participation 
is useful in cases where the patient was unaware of or denied problems.  
 The result of patients’ KBCI reveals improvement in apathy, somatic problems and 
emotional problems, and no changes in the other subscales or total scores.  However the 
patients’ caregivers showed that they perceived an improvement in overall behaviour as well 
as in communication and somatic problem subscales 
The existing evidence on effect of cranioplasty in changing behavior reveals 
conflicting results. Primrose reviewed 42 cases, 19 of whom were cured of their complaints, 
eight improved, five were unchanged, and two made worse.  Shuttleworth reported seven 
cases, four of whom were relieved of their complaints and two improved, while one was 
unchanged (13).  There are several studies showing improvement in headache after 
cranioplasty (13,14,16,27,37). 
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On the other hand, Termier followed 63 cases after cranioplasty and found that only a 
few psychotic patients had improved, though there was improvement in other aspects of the 
trephine syndromes (13).  Similarly, Lockhart et al stated that precranioplasty headaches, 
visual disturbances, difficulty in speech, convulsions, weakness of extremities and mental 
impairment were not changed by the repair of the cranial defect. (39) 
 
 Cranioplasty and executive function 
Improvement in basic cognition should have positive effect on executive functions, 
but while there is literature showing enhanced basic cognitive functions after cranioplasty 
there is no study demonstrating improvement in executive functions.  In this study the change 
in executive function after cranioplasty has been determined using the MET, which assesses 
executive functions in real life situations.  The total score of MET as well as the rule breaks 
subscale showed that there was a significant improvement in executive function after 
cranioplasty. Therefore cranioplasty has a positive effect not only on basic cognitive 
functions but on executive functions as well.  This improvement is also reflected in the 
significant improvement noted in MPAI4 domains of ability, adjustment and participation 
index, which are a direct result of improved executive functions.   
 
Cranioplasty and functional outcome 
The MPAI-4 is a four part assessment measure designed to evaluate a range of 
physical, cognitive, emotional, behavioral and social problems that patients confront during 
recovery from injury. The MPAI-4 provides measures of ability, adjustment and participation 
skill of patients.  
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The results of our study shows there is a significant improvement in these functional 
outcome measures (ability, adjustment and participation) after cranioplasty.  There is 
improvement, though not achieving statistical significance, in mobility, communication, self 
care and fund of information. Similarly adjustment also shows improvement in components 
of emotion, headache, fatigue, dizziness, vision and audition, and participation (the third 
component) showed improvement in social, vocational and familial dimensions of the index.     
Existing literature has shown improvement in speech, headache, apathy, fatigability 
and anger similar to our study (13, 14, 21, 50).  However, Lockhart et al stated that pre 
cranioplasty headaches, visual disturbances, difficulty in speech, convulsions, weakness of 
extremities and mental impairment were not changed by the repair of the cranial defect (39).   
 
Cranioplasty and motor function 
In our study five patients had motor weakness before cranioplasty.  Among the five 
patients 3 patients (60%) showed improvement in motor power and 2 patients (40%) 
remained unchanged after cranioplasty. One of the patients showed dramatic improvement, 
improving his hand function from unusable to fully functional.  Similar results have been 
reported by Chang et al., with improvement in motor deficit in 3 out of 4 patients (34).  There 
are several other studies which also report improvement in motor deficits after cranioplasty 
(14, 20, 21, 37,50). However Lockhart et al showed no change in motor function after 
cranioplasty (39).  
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Improvement after cranioplasty and severity of original injury 
To examine the effect of initial impact on the outcome after cranioplasty, patients 
were divided into three groups according the GCS score at the time of brain injury.  The only 
positive finding in this analysis was that the KBCI caregiver’s score showed significant 
improvement in behavior among the mild head injury patients as compared to moderate head 
injured patients. Hence, it can be concluded that the initial impact of trauma at the time head 
injury did not have effect on cognitive, executive, or functional outcome after cranioplasty.  
 
Interval between injury and cranioplasty 
The influence of the timing of cranioplasty after the decompression is unknown.  We 
divided patients into three groups according the time duration between the decompressive 
surgery and cranioplasty, and analysed outcomes in these groups.  The only significant 
influence of the interval was on the caregivers’ perception of behavior, while all other tests 
showed no difference.  Hence, we can conclude that once a patient has become neurologically 
stable the timing of cranioplasty will not have significant effect on cognition, functional and 
executive outcome. 
 
Cranioplasty and location of defect 
      The location of the decompression had no influence on the degree of improvement.  
This is probably because each patient in this study acts as his own control, and the deficit 
improvement is from their own baseline. 
 
Subjective assessment of improvement 
      Patients and caregivers were asked to fill out a qualitative assessment scale to assess 
their impression of change after surgery.  Out of 15 patients, 13 (86.7%) reported 
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improvement, 1 patient (6.7%) reported worsening after surgery and 1 patient (6.7%) 
reported no change.  On the same scale 11 (73.3%) caregivers reported improvement and 4 
(26.7%) no change.  None of the caregivers found any worsening.  Thus the majority of 
patients and caregivers felt there was improvement after surgery. 
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CONCLUSIONS 
  
1. Cranioplasty results in statistically significant improvement in components of motor, 
cognitive, behavioural and executive functions, with a corresponding improvement in 
the functional outcome of the patient. 
2. Location of defect, interval between surgery and cranioplasty and initial severity of 
injury did not have any impact on the outcome after cranioplasty. 
 
Strength of the study 
The present study holds many strong points which makes the study more relevant and 
reliable.  The current study is a pioneer study in India having a comprehensive approach in 
terms of outcome measure, which covers most of domains, physical, mental, social, and 
environmental, mentioning in international classification of functioning.    Secondly, it can be 
considered as a pilot study for a further detailed study of improvement in cognition, behavior, 
executive function, motor function and functional outcome after cranioplasty with 
appropriate psychometric tests in a systemic manner. Apart from that, the study design makes 
the study more reliable by selecting the patients for cranioplasty after a stable ACE-R score. 
The tools used for assessing cognition and functional outcome variables are universally 
standardized and have sensitivity and specificity. The MET, test used in the study, taping the 
executive functioning by asking the patient to do certain real life situation rather than 
laboratory test, which makes known changes in real life. Similarly, the other tests ACE-R and 
MPAI-4, are free of inter rater bias since pre and post assessment had done by different well 
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trained staffs. As part of managing bias, the cognitive assessment was done independently 
from the team that carried out the surgical procedure. Besides, patients and relatives were not 
informed about the possible improvement which prevented the occurrence of placebo effect. 
Limitations and suggestions for future study 
Although the study has been conducted keeping in mind all the procedures and pitfalls 
of research, certain limitation has crept into it.  First, the size of the sample is small. Hence, 
caution is warranted while interpreting the results.  Selection of large sample size, in future 
studies, is required to rectify the problem.  Also, future studies would benefit from different 
control group.  Second, duration of follow up, i.e., three months, can be inadequate post 
assessment period. In further studies, increasing the post assessment period will give more 
reliable result.  Third, the sampling technique employed for the study is purposive sampling 
which is uncertain in normal distribution. It can be rectified by using non-purposive sampling 
technique or conducting a randomized controlled trial for further studies.  
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Appendix 1: PREOPERATIVE PROFORMA 
 
 
 
CHANGES IN COGNITIVE AND NEUROLOGICAL FUNCTIONS IN PATIENTS 
UNDERGOING CRANIOPLASTY FOR LARGE CRANIOTOMY DEFECTS 
 
 
Name:     Hospital Number:    Unit: 
 
 
Age:     Sex:      
 
 
Address:  
 
 
 
Date of Trauma:      
 
GCS before surgery:     GCS at discharge: 
 
Date of decompressive craniectomy:     Date of cranioplasty: 
 
 
Time interval between decompressive craniectomy & cranioplasty:  
 
 
 
1. Mayo-Portland Adaptability Inventory-4 
  
 Ability Adjustment Participation Pre existing 
and associated 
condition 
     
Preop score     
Postop score     
 
 
    
 
 2. ACE – R (Pre operative) 
 
 
1 2 3 4 5 
Date      
Score      
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3. ACE – R (Post operative) 
 
 
Date  
Score  
 
 
 
 
 
4. MOTOR POWER-(Pre operative) 
 
 
R UL L UL  R LL L LL 
Shoulder-Flexion   Hip    -Flexion   
               -Extension             Extension   
Elbow    -Flexion   Knee -Flexion   
              -Extension                         Extension   
Wrist    -Flexion   Ankle D.Flexion   
             -Extension              P.Flexion   
Hand grip      
 
 
 
 
 
5. MOTOR POWER-(Postoperative); 
 
 
R UL L UL  R LL L LL 
Shoulder-Flexion   Hip    -Flexion   
               -Extension             Extension   
Elbow    -Flexion   Knee -Flexion   
              -Extension                    Extension   
Wrist    -Flexion   Ankle D.Flexion   
             -Extension              P.Flexion   
Hand grip      
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6. KBCI 
 
 Preop Postop 
Inattention   
Impulsivity   
Unawareness of problems   
Apathy   
Interpersonal difficulties   
Communication problems   
Somatic difficulties   
 
Note:  
 
 
 
 
 
 
 
 
7. MET: 
 
 Preop Postop 
Inefficiencies   
Rule breaks   
Task failures   
Interpretation failures   
Total Numbers of errors   
 
 
SUBJECTIVE ASSESSMENT: 
 
Patient’s subjective assessment post cranioplasty: Improvement/No improvement 
Caregiver’s subjective assessment post cranioplasty: Improvement/No improvement 
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Appendix 2 : INFORMED CONSENT 
Patient information.  
  Cranioplasty is a surgical procedure performed on patients where a portion of the 
skull removed during the first surgery is replaced by artificial bone. Other than cosmetic and 
protective function some studies suggest that this surgical procedure of replacing the skull 
bone has added benefits related to improvements in neurological function, particularly in the 
ability of a patient to understand, plan and execute specified acts. In order to study the effect 
of this procedure the patient will be evaluated via a physical exam and a written cognitive test 
before and three months after surgery.  The surgical procedure involved in this study is not 
different and is routinely practiced. The assessment will be performed prior to the operation 
and for one month afterwards serially for three months. 
  The data thus collected will be used for the benefit of future patients. The data thus 
obtained will be accessed by the investigators of the study, ethics committee and the 
publishers (in case the study is published later). However, the patient’s identity will not be 
revealed in any information released to third parties or published. If you are willing to 
participate in this study, you would have to be willing to agree to a physical examination and 
a cognitive assessment before and 3 months after surgery.   
However, this participation is entirely voluntary and your care in this hospital will not 
be affected by your decision. If you are willing you are required to give your consent by 
signing the following form. You have the right to withdraw from the study at any time. 
(i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
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

free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw from the trial. I agree to 
this access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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Appendix 3: QUALITATIVE DATA SHEET 
Name of Patient:         Date: 
For Patient  
Do you feel any significant change after cranioplasty?   
Improved / Same / Worse                              
If so please explain: 
 
 
For Relative 
Do you find any significant change in the patient after cranioplasty?   
Improved / Same / Worse                              
If so please explain: 
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Appendix-4: MAYO PORTLAND ADAPTIBILITY INVENTORY-4 (MPI-4) 

 
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Appedix-5: ADDENBROOKE’S COGNITIVE EXAMINATION-R (ACE-R) 
 


 


 
	

 



 
 
	

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Appendix-6: KEY BEHAVIOR CHANGE INVENTORY (KBCI) 
Key Behavior Change Inventory (KBCI) 
 
This version is to be completed by the PATIENT or individual who sustained some type of 
injury to describe the CURRENT LEVEL OF FUNCTIONING.   
 
 
Name:  ____________________________________________ Today’s Date:  ____________ 
 
Birthdate:  ____________________ 
 
Age:  __________________ 
 
Gender:    Male           Female 
 
Type of Injury:  
________________________________________________________________ 
 
___________________________________________________________________________
___ 
 
 
Date of Injury:  ______________ 
 
 
 
 
 
 
 
 
Please read the following items and answer them  
 
as to how they apply to you at this time. 
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KBCI:  Self-Rating Version:  Current Functioning 
 
Patient’s Name:  _________________________________ 
 
The following is a series of statements that can apply to people.  We would like to know how 
well each of these statements describes you.  Read each statement carefully and decide how 
well that statement fits you. Mark your answers by circling a response according to the 
following key: 
 
F     =  False, not at all 
ST   =  Slightly True 
MT  =  Mostly True 
VT   =  Very True 
 
 
 I:     
1.  usually remember appointments, chores, and  
     things I need to do 
 
F 
 
ST 
 
MT 
 
VT 
2.  plan things out ahead of time F ST MT VT 
3.  care about other people F ST MT VT 
4.  have very little interest in things F ST MT VT 
5.  frequently feel tired 
 
F ST MT VT 
6.  know my limitations F ST MT VT 
7.  often don’t get the humor in jokes F ST MT VT 
8.  seem happy most of the time F ST MT VT 
9.  have trouble following directions F ST MT VT 
10. say or do the first thing that comes to mind 
 
F ST MT VT 
11. get into arguments easily F ST MT VT 
12. frequently sit for long periods of time and do 
     nothing 
 
F 
 
ST 
 
MT 
 
VT 
13. feel dizzy F ST MT VT 
14. get into trouble and don’t understand why F ST MT VT 
15. say things that don’t make much sense 
 
F ST MT VT 
16. have an even temper F ST MT VT 
17. misplace and lose things F ST MT VT 
18. am deliberate and careful F ST MT VT 
19. do things without thinking about other people’s  
     feelings 
F ST MT VT 
20. need encouragement to do things F ST MT VT 
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F     =  False, not at all 
ST   =  Slightly True 
MT  =  Mostly True 
VT   =  Very True 
 
 I:     
21. am not overly concerned about my health F ST MT VT 
22. have poor insight into my problems F ST MT VT 
23. talk too much F ST MT VT 
24. am positive about the future F ST MT VT 
25. get confused easily 
 
F ST MT VT 
26. act unpredictably F ST MT VT 
27. am polite in social situations F ST MT VT 
28. am creative F ST MT VT 
29. frequently have headaches F ST MT VT 
30. can recognize when I am beginning to get 
     upset 
 
 
F 
 
ST 
 
MT 
 
VT 
31. talk too loudly or softly F ST MT VT 
32. am easily hurt by criticism F ST MT VT 
33. have trouble with details F ST MT VT 
34. am too hasty in my actions F ST MT VT 
35. am sensitive to other people’s feelings and needs 
 
F ST MT VT 
36. get little pleasure out of life F ST MT VT 
37. don’t let normal aches and pains bother 
     me 
 
F 
 
ST 
 
MT 
 
VT 
38. think I can do things I really can’t F ST MT VT 
39. listen carefully and respond normally when 
     talking with others 
 
F 
 
ST 
 
MT 
 
VT 
40. feel worthless 
 
F ST MT VT 
41. concentrate easily on what I am doing F ST MT VT 
42. often act without thinking F ST MT VT 
43. am self-centered F ST MT VT 
44. am enterprising and energetic F ST MT VT 
45. often do not feel well 
 
F ST MT VT 
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F     =  False, not at all 
ST   =  Slightly True 
MT  =  Mostly True 
VT   =  Very True 
 
 I:     
46. don’t realize it when my actions are not getting 
    the job done 
 
F 
 
ST 
 
MT 
 
VT 
47. speak at an appropriate volume and speed F ST MT VT 
48. am moody and irritable F ST MT VT 
49. am attentive and sharp F ST MT VT 
50. cannot wait patiently 
 
F ST MT VT 
51. try to see how much I can get away with F ST MT VT 
52. think about the future and set goals for  
     myself 
 
F 
 
ST 
 
MT 
 
VT 
53. usually feel dissatisfied with my medical  
     treatment 
 
F 
 
ST 
 
MT 
 
VT 
54. recognize when others are having trouble  
     following what I am saying 
 
F 
 
ST 
 
MT 
 
VT 
55. talk in a way that makes sense (it is easy to  
     follow my train of thought) 
 
 
F 
 
ST 
 
MT 
 
VT 
56. cope poorly with stress F ST MT VT 
57. am able to focus on a chore or task until finished F ST MT VT 
58. carefully think things through F ST MT VT 
59. get along well with other people  F ST MT VT 
60. have good ideas and work on them 
 
F ST MT VT 
61. use health problems as an excuse to avoid  
     chores or duties 
 
F 
 
ST 
 
MT 
 
VT 
62. realize errors and mistakes, and try to correct  
     them when they occur 
 
F 
 
ST 
 
MT 
 
VT 
63. stick to the topic when talking to others F ST MT VT 
64. adjust well to life’s difficulties F ST MT VT 
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Appendix-7: MULTIPLE ERRAND’S TEST (MET) 
MET 
Instructions For the Participants 
 
 
In this exercise you have to complete three tasks 
Task I Do the following 6 things  
1. Collect something for the examiner from the secretarary and do what is  
      necessary. 
2.   Buy one Rs.5/- stamp from the secretarary.  
3.   Buy a post cover from canteen. 
4.   Buy a packet of mango/Apple juice. 
5. Telephone at reception from inside the centre and say who you are, where you are, 
and what is the time. (Telephone no. 4549) 
 
6. Post some thing for Suhany. (Post Box is inside the secretararie’s cabin) 
 
 Task II Collect the following information and write down in the space below: 
 
1.   What is the closing time of pharmacy on Saturday? 
2. What is the opening time of cash counter? 
3. What is the price of a packet of glucose? 
4.   How many main entrances are there in this campus?  
 
Task III You must meet the PMR receptionist after 30 minutes and tell the time 
Tell the person observing when you have completed the exercise. 
The rules you must follow: 
• You must carry out all these tasks but may do so in any order. 
• You should spend no more than Rs.40/-. 
• You should not enter any of the hospital wards or “staff only” areas. 
• No building should be entered other than to complete part of the task inside. 
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• Take as little time to complete this exercise without rushing excessively. 
• Do not speak to the person observing you unless this is part of the exercise. 
 
   Your examiner is: 
Suhany B T 
Psychologist 
PMR, Bagayam, CMC 
Vellore, Tamil Nadu. 
 
Space to write down answer: 
 
 
You will be provided with 
 
1. Instruction sheet 
2. A pen 
3. Carrier bag 
4. Rs.40/- 
5.   Watch 
How well you have done the task 
 
 
 
           1         2       3       4        5       6       7         8        9       10 
    Hopeless       Excellent 
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MET SCORING SHEET 
DPMR, CMC, Vellore 
 
 
 
Quantitative Analysis 
 
Inefficiencies 
 
 
Rule breaks  
 
 
Task failures  
 
 
Interpretation failures 
 
 
Total number of errors  
 
 


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